FDA label
What is Ubrelvy used for?
Ubrelvy contains ubrogepant. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “UBRELVY is indicated for the acute treatment of migraine with or without aura in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Ubrelvy?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Ubrelvy, tablet
Indications and Usage, quoted from the label by Sportpharm LLC (NDA211765). Cross-references to other label sections are left out.
UBRELVY is indicated for the acute treatment of migraine with or without aura in adults.
Limitations of Use
UBRELVY is not indicated for the preventive treatment of migraine.
Source: DailyMed label, set id 36106b14-d410-4faf-a361-2871de8198c3, version 1, effective September 29, 2026. NDC 85766-280, one of 4 listings for this product.
Questions
What is Ubrelvy used for?
The FDA label says: “UBRELVY is indicated for the acute treatment of migraine with or without aura in adults.”
What drug class is Ubrelvy?
FDA lists ubrogepant in the Calcitonin Gene-related Peptide Receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.